Advertisement

Evaluation of Thyroid Nodules

  • Michel Procopiou
  • Christoph A. Meier
Chapter
  • 1.1k Downloads

Keywords

Thyroid Cancer Thyroid Nodule Medullary Thyroid Cancer Multinodular Goiter Suppressive Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abbas G, Heller KS, Khoynezhad A, Dubner S, Sznyter LA (2001) The incidence of carcinoma in cytologically benign thyroid cysts. Surgery 130:1035–1038PubMedCrossRefGoogle Scholar
  2. 2.
    Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Marqusee E (2002) Assessment of nondiagnostic ultrasound-guided fine-needle aspirations of thyroid nodules. J Clin Endocrinol Metab 87:4924–4927PubMedCrossRefGoogle Scholar
  3. 3.
    Alexander EK, Hurwitz S, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, Larsen PR, Marqusee E (2003) Natural history of benign solid and cystic thyroid nodules. Ann Intern Med 138:315–318PubMedGoogle Scholar
  4. 4.
    Badillo J, Shimaoka K, Lessmann EM, Marchetta FC, Sokal JE (1963) Treatment of nontoxic goiter with sodium liothyronine. A double-blind study. JAMA 184:29–36PubMedGoogle Scholar
  5. 5.
    Bartolazzi A (2000) Improving accuracy of cytology for nodular thyroid lesions. Lancet 355:1661–1662PubMedCrossRefGoogle Scholar
  6. 6.
    Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644–1650PubMedCrossRefGoogle Scholar
  7. 7.
    Belfiore A, La Rosa GL (2001) Fine-needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am 30:361–400PubMedCrossRefGoogle Scholar
  8. 8.
    Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity [see comments]. Am J Med 93:363–369PubMedCrossRefGoogle Scholar
  9. 9.
    Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL (1990) Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 336:193–197PubMedCrossRefGoogle Scholar
  10. 10.
    Bistrup C, Nielsen JD, Gregersen G, Franch P (1994) Preventive effect of levothyroxine in patients operated for non-toxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol (Oxf) 40:323–327CrossRefGoogle Scholar
  11. 11.
    Bojunga J, Zeuzem S (2004) Molecular detection of thyroid cancer: an update. Clin Endocrinol (Oxf) 61:523–530CrossRefGoogle Scholar
  12. 12.
    Braga M, Cavalcanti TC, Collaco LM, Graf H (2001) Efficacy of ultrasound-guided fine-needle aspiration biopsy in the diagnosis of complex thyroid nodules. J Clin Endocrinol Metab 86:4089–4091PubMedCrossRefGoogle Scholar
  13. 13.
    Brander A, Viikinkoski P, Nickels J, Kivisaari L (1991) Thyroid gland: US screening in a random adult population. Radiology 181:683–687PubMedGoogle Scholar
  14. 14.
    Burch HB (1995) Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 24:663–710PubMedGoogle Scholar
  15. 15.
    Burguera B, Gharib H (2000) Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 29:187–203PubMedCrossRefGoogle Scholar
  16. 16.
    Castro MR, Caraballo PJ, Morris JC (2002) Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154–4159PubMedCrossRefGoogle Scholar
  17. 17.
    Cheung PS, Lee JM, Boey JH (1989) Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 13:818–821PubMedCrossRefGoogle Scholar
  18. 18.
    Ciampi R, Knauf JA, Kerler R, Gandhi M, Zhu Z, Nikiforova MN, Rabes HM, Fagin JA, Nikiforov YE (2005) Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. J Clin Invest 115:94–101PubMedCrossRefGoogle Scholar
  19. 19.
    Clark KC, Moffat FL, Ketcham AS, Legaspi A, Robinson DS (1991) Nonoperative techniques for tissue diagnosis in the management of thyroid nodules and goiters. Semin Surg Oncol 7:76–80PubMedGoogle Scholar
  20. 20.
    Cole WH (1991) Incidence of carcinoma of the thyroid in nodular goiter. Semin Surg Oncol 7:61–63PubMedGoogle Scholar
  21. 21.
    Date J, Feldt-Rasmussen U, Blichert-Toft M, Hegedus L, Graversen HP (1996) Long-term observation of serum thyroglobulin after resection of nontoxic goiter and relation to ultrasonographically demonstrated relapse. World J Surg 20:351–357PubMedCrossRefGoogle Scholar
  22. 22.
    de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL (1990) Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med 150:1422–1427PubMedCrossRefGoogle Scholar
  23. 23.
    Delange F (2000) Iodine deficiency. In: Braverman LE, Utiger RD (eds) Werner & Ingbar’s the thyroid. Lippincott Williams & Wilkins, Philadelphia, pp 295–316Google Scholar
  24. 24.
    Derwahl M, Studer H (2000) Multinodular goitre: “much more to it than simply iodine deficiency”. Baillieres Best Pract Res Clin Endocrinol Metab 14:577–600PubMedCrossRefGoogle Scholar
  25. 25.
    Dumont JE, Ermans AM, Maenhaut C, Coppee F, Stanbury JB (1995) Large goitre as a maladaptation to iodine deficiency. Clin Endocrinol (Oxf) 43:1–10Google Scholar
  26. 26.
    Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163–168PubMedCrossRefGoogle Scholar
  27. 27.
    Favus MJ, Schneider AB, Stachura ME, Arnold JE, Ryo UY, Pinsky SM, Colman M, Arnold MJ, Frohman LA (1976) Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. N Engl J Med 294:1019–1025PubMedCrossRefGoogle Scholar
  28. 28.
    Feilchenfeldt J, Totsch M, Sheu SY, Robert J, Spiliopoulos A, Frilling A, Schmid KW, Meier CA (2003) Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Mod Pathol 16:1117–1123PubMedCrossRefGoogle Scholar
  29. 29.
    Fogelfeld L, Wiviott MB, Shore-Freedman E, Blend M, Bekerman C, Pinsky S, Schneider AB (1989) Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions. N Engl J Med 320:835–840PubMedCrossRefGoogle Scholar
  30. 30.
    Foley TPJ (1993) Goiter in adolescents. Endocrinol Metab Clin North Am 22:593–606PubMedGoogle Scholar
  31. 31.
    Gaitan E (1990) Intervention policy in endemic goitre areas. Thyroidology 2:113–119PubMedGoogle Scholar
  32. 32.
    Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A (1999) Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494–3502PubMedGoogle Scholar
  33. 33.
    Gharib H (1994) Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 69:44–49PubMedGoogle Scholar
  34. 34.
    Gharib H (1997) Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 26:777–800PubMedCrossRefGoogle Scholar
  35. 35.
    Gharib H, Goellner JR (1993) Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282–289PubMedGoogle Scholar
  36. 36.
    Gharib H, Mazzaferri EL (1998) Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 128:386–394PubMedGoogle Scholar
  37. 37.
    Gharib H, Goellner JR, Zinsmeister AR, Grant CS, van Heerden JA (1984) Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Ann Intern Med 101:25–28PubMedGoogle Scholar
  38. 38.
    Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA (1987) Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study. N Engl J Med 317:70–75PubMedCrossRefGoogle Scholar
  39. 39.
    Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR (1989) Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 106:980–986PubMedGoogle Scholar
  40. 40.
    Hamburger JI (1994) Diagnosis of thyroid nodules by fine-needle biopsy: use and abuse. J Clin Endocrinol Metab 79:335–339PubMedCrossRefGoogle Scholar
  41. 41.
    Hamming JF, Goslings BM, van Steenis GJ, van Ravenswaay Claasen H, Hermans J, van de Velde CJ (1990) The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med 150:113–116PubMedCrossRefGoogle Scholar
  42. 42.
    Hegedus L (2001) Thyroid ultrasound. Endocrinol Metab Clin North Am 30:339–360PubMedCrossRefGoogle Scholar
  43. 43.
    Hegedus L, Nygaard B, Hansen JM (1999) Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 84:756–760PubMedCrossRefGoogle Scholar
  44. 44.
    Hegedus L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102–132PubMedCrossRefGoogle Scholar
  45. 45.
    Henneman G (2000) Multinodular goiter. The thyroid and its diseases. www.thyroidmanager.orgGoogle Scholar
  46. 46.
    Koc M, Ersoz HO, Akpinar I, Gogas-Yavuz D, Deyneli O, Akalin S (2002) Effect of low-and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial. Clin Endocrinol (Oxf) 57:621–628CrossRefGoogle Scholar
  47. 47.
    Koh KB, Chang KW (1992) Carcinoma in multinodular goitre. Br J Surg 79:266–267PubMedGoogle Scholar
  48. 48.
    Kroll TG, Sarraf P, Pecciarini L, Chen C, Mueller E, Spiegelman BM, Fletcher JA (2000) PAX8-PPARy1 fusion in oncogenic human thyroid carcinoma. Science 289:1357–1360PubMedCrossRefGoogle Scholar
  49. 49.
    Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M (1994) Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 18:495–498PubMedCrossRefGoogle Scholar
  50. 50.
    La Rosa GL, Belfiore A, Giuffrida D, Sicurella C, Ippolito O, Russo G, Vigneri R (1991) Evaluation of the fine-needle aspiration biopsy in the preoperative selection of cold thyroid nodules. Cancer 67:2137–2141PubMedCrossRefGoogle Scholar
  51. 51.
    La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1–8PubMedGoogle Scholar
  52. 52.
    Levy EG, Greenlee C, Mandel S, Kaplan M (2000) Should you always trust FNA interpretations? Thyroid 10:279–280PubMedCrossRefGoogle Scholar
  53. 53.
    Liel Y (1999) The yield of adequate and conclusive fine-needle aspiration results in thyroid nodules is uniform across functional and goiter types. Thyroid 9:25–28PubMedGoogle Scholar
  54. 54.
    Lima N, Knobel M, Cavaliere H, Sztejnsznajd C, Tomimori E, Medeiros-Neto G (1997) Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters. Thyroid 7:691–697PubMedGoogle Scholar
  55. 55.
    Lucas A, Llatjos M, Salinas I, Reverter J, Pizarro E, Sanmarti A (1995) Fine-needle aspiration cytology of benign nodular thyroid disease. Value of re-aspiration. Eur J Endocrinol 132:677–680PubMedGoogle Scholar
  56. 56.
    Madeddu G, Casu AR, Marrosu A, Marras G, Langer M (1984) Serum thyroglobulin in patients with autonomous thyroid nodules. Clin Endocrinol (Oxf) 21:377–382Google Scholar
  57. 57.
    Mandel SJ (2004) A 64-year-old woman with a thyroid nodule. JAMA 292:2632–2642PubMedCrossRefGoogle Scholar
  58. 58.
    Mazzaferri EL (1992) Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 93:359–362PubMedCrossRefGoogle Scholar
  59. 59.
    Mazzaferri EL (1993) Management of a solitary thyroid nodule. N Engl J Med 328:553–559PubMedCrossRefGoogle Scholar
  60. 60.
    Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428PubMedCrossRefGoogle Scholar
  61. 61.
    McCall A, Jarosz H, Lawrence AM, Paloyan E (1986) The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 100:1128–1132PubMedGoogle Scholar
  62. 62.
    McHenry CR, Walfish PG, Rosen IB (1993) Non-diagnostic fine-needle aspiration biopsy: a dilemma in management of nodular thyroid disease. Am Surg 59:415–419PubMedGoogle Scholar
  63. 63.
    Mehrotra P, Okpokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR, Lennard TW (2004) Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 45:493–500PubMedCrossRefGoogle Scholar
  64. 64.
    Meier CA (2000) Thyroid nodules: pathogenesis, diagnosis and treatment. Baillieres Best Pract Res Clin Endocrinol Metab 14:559–575PubMedCrossRefGoogle Scholar
  65. 65.
    Mikosch P, Gallowitsch HJ, Kresnik E, Jester J, Wurtz FG, Kerschbaumer K, Unterweger O, Dinges HP, Lind P (2000) Value of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in an endemic goitre area. Eur J Nucl Med 27:62–69PubMedCrossRefGoogle Scholar
  66. 66.
    Modigliani E, Franc B, Niccoli-Sire P (2000) Diagnosis and treatment of medullary thyroid cancer. Baillieres Best Pract Res Clin Endocrinol Metab 14:631–649PubMedCrossRefGoogle Scholar
  67. 67.
    Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B (1997) Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 82:338–341PubMedCrossRefGoogle Scholar
  68. 68.
    Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A (1998) Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 58:3015–3020PubMedGoogle Scholar
  69. 69.
    Pacini F, Vorontsova T, Demidchik EP, Molinaro E, Agate L, Romei C, Shavrova E, Cherstvoy ED, Ivashkevitch Y, Kuchinskaya E, Schlumberger M, Ronga G, Filesi M, Pinchera A (1997) Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 82:3563–3569PubMedCrossRefGoogle Scholar
  70. 70.
    Papini E, Bacci V, Panunzi C, Pacella CM, Fabbrini R, Bizzarri G, Petrucci L, Giammarco V, La Medica P, Masala M (1993) A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf) 38:507–513Google Scholar
  71. 71.
    Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM (1998) Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 83:780–783PubMedCrossRefGoogle Scholar
  72. 72.
    Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941–1946PubMedCrossRefGoogle Scholar
  73. 73.
    Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861–865PubMedCrossRefGoogle Scholar
  74. 74.
    Pelizzo MR, Piotto A, Rubello D, Casara D, Fassina A, Busnardo B (1990) High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori 76:255–257PubMedGoogle Scholar
  75. 75.
    Pinchera A, Aghini-Lombardi F, Antonangeli L, Vitti P (1996) Multinodular goiter. Epidemiology and prevention. Ann Ital Chir 67:317–325PubMedGoogle Scholar
  76. 76.
    Radecki PD, Arger PH, Arenson RL, Jennings AS, Coleman BG, Mintz MC, Kressel HY (1984) Thyroid imaging: comparison of high-resolution real-time ultrasound and computed tomography. Radiology 153:145–147PubMedGoogle Scholar
  77. 77.
    Read CH Jr, Tansey MJ, Menda Y (2004) A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves’ patients. J Clin Endocrinol Metab 89:4229–4233PubMedCrossRefGoogle Scholar
  78. 78.
    Reverter JL, Lucas A, Salinas I, Audi L, Foz M, Sanmarti A (1992) Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocrinol (Oxf) 36:25–28Google Scholar
  79. 79.
    Richter B, Neises G, Clar C (2002) Pharmacotherapy for thyroid nodules. A systematic review and meta-analysis. Endocrinol Metab Clin North Am 31:699–722PubMedCrossRefGoogle Scholar
  80. 80.
    Rojdmark J, Jarhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 161:725–727PubMedGoogle Scholar
  81. 81.
    Rzepka AH, Cissewski K, Olbricht T, Reinwein D (1994) Effectiveness of prophylactic therapy on goiter recurrence in an area with low iodine intake: a sonographic follow-up study. Clin Investig 72:967–970PubMedCrossRefGoogle Scholar
  82. 82.
    Sampson RJ, Key CR, Buncher CR, Iijima S (1969) Thyroid carcinoma in Hiroshima and Nagasaki. I. Prevalence of thyroid carcinoma at autopsy. JAMA 209:65–70PubMedCrossRefGoogle Scholar
  83. 83.
    Sampson RJ, Woolner LB, Bahn RC, Kurland LT (1974) Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer 34:2072–2076PubMedCrossRefGoogle Scholar
  84. 84.
    Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D’Agostino RB (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249–1252PubMedCrossRefGoogle Scholar
  85. 85.
    Schlinkert RT, van Heerden JA, Goellner JR, Gharib H, Smith SL, Rosales RF, Weaver AL (1997) Factors that predict malignant thyroid lesions when fine-needle aspiration is suspicious for follicular neoplasm. Mayo Clin Proc 72:913–916PubMedGoogle Scholar
  86. 86.
    Schneider AB (1990) Radiation-induced thyroid tumors. Endocrinol Metab Clin North Am 19:495–508PubMedGoogle Scholar
  87. 87.
    Schneider AB, Favus MJ, Stachura ME, Arnold J, Arnold MJ, Frohman LA (1978) Incidence, prevalence and characteristics of radiation-induced thyroid tumors. Am J Med 64:243–252PubMedCrossRefGoogle Scholar
  88. 88.
    Schneider AB, Shore-Freedman E, Ryo UY, Bekerman C, Favus M, Pinsky S (1985) Radiation-induced tumors of the head and neck following childhood irradiation. Prospective studies. Medicine (Baltimore) 64:1–15PubMedCrossRefGoogle Scholar
  89. 89.
    Schneider AB, Recant W, Pinsky SM, Ryo UY, Bekerman C, Shore-Freedman E (1986) Radiation-induced thyroid carcinoma. Clinical course and results of therapy in 296 patients. Ann Intern Med 105:405–412PubMedGoogle Scholar
  90. 90.
    Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC (1993) Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 77:362–369PubMedCrossRefGoogle Scholar
  91. 91.
    Schoder H, Yeung HW (2004) Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med 34:180–197PubMedCrossRefGoogle Scholar
  92. 92.
    Sherman SI (2003) Thyroid carcinoma. Lancet 361:501–511PubMedCrossRefGoogle Scholar
  93. 93.
    Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG (1996) Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 156:2165–2172PubMedCrossRefGoogle Scholar
  94. 94.
    Sokal JE (1957) A long term follow-up of non-toxic nodular goitre. JAMA 99:60Google Scholar
  95. 95.
    Solbiati L, Volterrani L, Rizzatto G, Bazzocchi M, Busilacci P, Candiani F, Ferrari F, Giuseppetti G, Maresca G, Mirk P (1985) The thyroid gland with low uptake lesions: evaluation by ultrasound. Radiology 155:187–191PubMedGoogle Scholar
  96. 96.
    Spencer CA (2000) Thyroglobulin. In: Braverman LE, Utiger RD (eds) Werner & Ingbar’s the thyroid. Lippincott Williams & Wilkins, Philadelphia, pp 402–413Google Scholar
  97. 97.
    Stoffer RP, Welch JP, Hellwig CA, Chesky WE, McCusker EN (1960) Nodular goitre. Arch Intern Med 106:10Google Scholar
  98. 98.
    Tan GH, Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226–231PubMedGoogle Scholar
  99. 99.
    Tollin SR, Mery GM, Jelveh N, Fallon EF, Mikhail M, Blumenfeld W, Perlmutter S (2000) The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid 10:235–241PubMedCrossRefGoogle Scholar
  100. 100.
    Topliss D (2004) Thyroid incidentaloma: the ignorant in pursuit of the impalpable. Clin Endocrinol (Oxf) 60:18–20CrossRefGoogle Scholar
  101. 101.
    Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481–493Google Scholar
  102. 102.
    Tuttle RM, Lemar H, Burch HB (1998) Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8:377–383PubMedGoogle Scholar
  103. 103.
    Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278–4289PubMedCrossRefGoogle Scholar
  104. 104.
    Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B (1997) Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589–1593PubMedCrossRefGoogle Scholar
  105. 105.
    Wang C, Crapo LM (1997) The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26:189–218PubMedCrossRefGoogle Scholar
  106. 106.
    Wemeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C, Vlaeminck-Guillem V (2002) Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87:4928–4934PubMedCrossRefGoogle Scholar
  107. 107.
    Wesche MF, Tiel VBMM, Lips P, Smits NJ, Wiersinga WM (2001) A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 86:998–1005PubMedCrossRefGoogle Scholar
  108. 108.
    Zelmanovitz F, Genro S, Gross JL (1998) Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881–3885PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  • Michel Procopiou
    • 1
  • Christoph A. Meier
    • 2
  1. 1.Division of Endocrinology, Diabetes and Nutrition, Department of Internal MedicineUniversity Hospital GenevaGeneva 14Switzerland
  2. 2.Endocrine Unit, Division of Endocrinology, Diabetes and Nutrition, Department of Internal MedicineUniversity Hospital GenevaGeneva 14Switzerland

Personalised recommendations